• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 03/06/15

    • 30-Day SEC Yield1

      1.18%
    • Total Net Assets

      $377.4M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.42%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2015
  • Portfolio Composition (%)
    as of 03/06/15

    • % of Net Assets
    • Stocks

      99.70
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.30
  • Download All HoldingsAll Holdings (%) as of 03/06/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Novartis Ag
    NVS US
    348,248
    33,940,2508.99
    Johnson & Johnson
    JNJ US
    314,703
    31,504,9178.35
    Pfizer Inc
    PFE US
    751,058
    25,513,4406.76
    Valeant Pharmaceuticals International I
    VRX US
    99,388
    19,749,3895.23
    Glaxosmithkline Plc
    GSK US
    414,724
    19,380,0535.14
    Sanofi
    SNY US
    393,293
    18,649,9544.94
    Novo Nordisk A/S
    NVO US
    393,978
    18,323,9174.86
    Actavis Plc
    ACT US
    62,719
    18,183,4924.82
    Allergan Inc/United States
    AGN US
    77,261
    18,041,2164.78
    Bristol-Myers Squibb Co
    BMY US
    273,830
    17,831,8104.73
    Merck & Co Inc
    MRK US
    300,706
    17,092,1294.53
    Abbott Laboratories
    ABT US
    365,847
    17,011,8864.51
    Eli Lilly & Co
    LLY US
    228,468
    15,629,4964.14
    Shire Plc
    SHPG US
    64,875
    15,294,2814.05
    Abbvie Inc
    ABBV US
    266,887
    14,849,5933.94
    Astrazeneca Plc
    AZN US
    220,464
    14,610,1493.87
    Mckesson Corp
    MCK US
    64,152
    14,408,5393.82
    Teva Pharmaceutical Industries Ltd
    TEVA US
    254,742
    14,367,4493.81
    Zoetis Inc
    ZTS US
    144,033
    6,593,8311.75
    Perrigo Co
    PRGO US
    40,446
    6,343,1461.68
    Mylan Inc/Pa
    MYL US
    112,840
    6,255,8501.66
    Hospira Inc
    HSP US
    44,410
    3,903,6391.03
    Mallinckrodt Plc
    MNK US
    27,634
    3,352,8330.89
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    37,620
    3,274,0690.87
    Salix Pharmaceuticals Ltd
    SLXP US
    13,333
    2,106,7470.56
    Other/Cash
    1,147,4250.30
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.